TIGIT inhibition and lenalidomide synergistically promote antimyeloma immune responses after stem cell transplantation in mice

Autologous stem cell transplantation (ASCT) with subsequent lenalidomide maintenance is standard consolidation therapy for multiple myeloma, and a subset of patients achieve durable progression-free survival that is suggestive of long-term immune control. Nonetheless, most patients ultimately relaps...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnie, Simone A., Waltner, Olivia G., Ensbey, Kathleen S., Olver, Stuart D., Collinge, Alika D., Sester, David P., Schmidt, Christine R., Legg, Samuel R.W., Takahashi, Shuichiro, Nemychenkov, Nicole S., Sekiguchi, Tomoko, Driessens, Gregory, Zhang, Ping, Koyama, Motoko, Spencer, Andrew, Holmberg, Leona A., Furlan, Scott N., Varelias, Antiopi, Hill, Geoffrey R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927935/
https://www.ncbi.nlm.nih.gov/pubmed/36512425
http://dx.doi.org/10.1172/JCI157907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927935/
https://www.ncbi.nlm.nih.gov/pubmed/36512425
http://dx.doi.org/10.1172/JCI157907

Ejemplares similares